Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Hepatitis E | Research

Hepatitis E seroprevalence and risk factors in humans and pig in Ghana

Authors: Husein Bagulo, Ayodele O. Majekodunmi, Susan C. Welburn, Langbong Bimi

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Although Hepatitis E virus (HEV) infection has significant negative impact on the health and wellbeing of underprivileged populations, the burden of HEV in Ghana is still unclear, despite widespread water, sanitation, and hygiene (WASH) related conditions that predispose people to the risk of infection.

Methods

A cross-sectional study was conducted to explore rates of HEV seroprevalence and HEV prevalence, as well as risk factors in humans and domestic pigs in Ghana. These were determined using ELISAs manufactured by Wantai Beijing Biopharmaceuticals, China. The study involved 1365 community members, 105 pig farmers and 474 domestic pigs from four administrative regions of Ghana.

Results

Results showed overall seroprevalence and prevalence of 12.4% and 0.7% in community members and 15.2% and 2.9% in pig farmers respectively. There was no significant difference in the seroprevalence between the two groups (Z = 0.851; p = 0.3953). However, the prevalence in pig farmers was significantly higher than in community members (Z = 2.412; p = 0.016). Age (OR = 1.369, CI = 1.243 – 1.508; p = 0.0000), gender (OR = 1.419, CI = 1.101 – 1.991; p = 0.043), and the region of residence (OR = 1.569, CI = 1.348 – 1.827; p = 0.0000) were significant risk factors for HEV seroprevalence in a multivariate regression model.
In pigs, overall seroprevalence and prevalence of 62.4% and 5.5% were recorded respectively. A significant difference in seroprevalence was found between confined (6.7%) and free-range pigs (88.3%), (Z = 7.492; p < 0.00001) in the Volta Region. Multivariate logistic regression showed a significant association between seroprevalence and husbandry (OR = 7.051, CI = 3.558– 13.972; p = 0.0000) and region (OR = 4.602, CI = 2.300 – 9.205; p = 0.0000) in pigs in the Volta and Greater Accra Region.

Conclusion

From this study, HEV is endemic in Ghana with high seroprevalence in humans and pig populations. This underscores the need for awareness creation and action for prevention and control.
Literature
1.
go back to reference Zuckerman AJ. Hepatitis viruses. e LS. 2001. Zuckerman AJ. Hepatitis viruses. e LS. 2001.
2.
go back to reference Modiyinji AF, Atsama MA, Monamele GC, Nola M, Njouom R. High seroprevalence of hepatitis E among pigs suggests an animal reservoir in Cameroon. J Infect Devel Countr. 2018;12(08):676–9.CrossRef Modiyinji AF, Atsama MA, Monamele GC, Nola M, Njouom R. High seroprevalence of hepatitis E among pigs suggests an animal reservoir in Cameroon. J Infect Devel Countr. 2018;12(08):676–9.CrossRef
3.
go back to reference Wen G-P, Tang Z-M, Yang F, Zhang K, Ji W-F, Cai W, et al. A valuable antigen detection method for diagnosis of acute hepatitis E. J Clin Microbiol. 2015;53(3):782–8.CrossRef Wen G-P, Tang Z-M, Yang F, Zhang K, Ji W-F, Cai W, et al. A valuable antigen detection method for diagnosis of acute hepatitis E. J Clin Microbiol. 2015;53(3):782–8.CrossRef
4.
go back to reference Azman AS, Ciglenecki I, Wamala JF, Lynch J, Aggarwal R, Rahman M, et al. Hepatitis E should be considered a neglected tropical disease. PLoS Negl Trop Dis. 2019;13:7.CrossRef Azman AS, Ciglenecki I, Wamala JF, Lynch J, Aggarwal R, Rahman M, et al. Hepatitis E should be considered a neglected tropical disease. PLoS Negl Trop Dis. 2019;13:7.CrossRef
5.
go back to reference Bagulo H, Majekodunmi AO, Welburn SC. Hepatitis E in sub Saharan Africa–A significant emerging disease. One Health. 2020;1:100186.CrossRef Bagulo H, Majekodunmi AO, Welburn SC. Hepatitis E in sub Saharan Africa–A significant emerging disease. One Health. 2020;1:100186.CrossRef
6.
go back to reference Supply WUJW, Programme SM, Organization WH. Progress on sanitation and drinking water: 2015 update and MDG assessment: World Health Organization; 2015. Supply WUJW, Programme SM, Organization WH. Progress on sanitation and drinking water: 2015 update and MDG assessment: World Health Organization; 2015.
7.
go back to reference Dongzagla A, Jewitt S, O’Hara S. Seasonality in faecal contamination of drinking water sources in the Jirapa and Kassena-Nankana Municipalities of Ghana. Sci Total Environ. 2021;752:141846.CrossRef Dongzagla A, Jewitt S, O’Hara S. Seasonality in faecal contamination of drinking water sources in the Jirapa and Kassena-Nankana Municipalities of Ghana. Sci Total Environ. 2021;752:141846.CrossRef
8.
go back to reference Adjei A, Aviyase J, Tettey Y, Adu-Gyamfi C, Mingle J, Ayeh-Kumi P, et al. Hepatitis E virus infection among pig handlers in Accra, Ghana. East Afr Med J. 2009;86:8. Adjei A, Aviyase J, Tettey Y, Adu-Gyamfi C, Mingle J, Ayeh-Kumi P, et al. Hepatitis E virus infection among pig handlers in Accra, Ghana. East Afr Med J. 2009;86:8.
9.
go back to reference Yeboah R, Sylverken AA, Owusu M, El-Duah P, Burimuah V, Frimpong Y, et al. Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana. One Health Outlook. 2021;3(1):1–11.CrossRef Yeboah R, Sylverken AA, Owusu M, El-Duah P, Burimuah V, Frimpong Y, et al. Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana. One Health Outlook. 2021;3(1):1–11.CrossRef
10.
go back to reference Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Mingle JA, Nartey ET. Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra Ghana. Virol J. 2010;7:336.CrossRef Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Mingle JA, Nartey ET. Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra Ghana. Virol J. 2010;7:336.CrossRef
11.
go back to reference Tettey Y, Adjei A, Ayivase J, Adu-Gyamfi C, Mingle J, Nartey E, et al. Serological evidence of hepatitis E virus infection among volunteer blood donors at the Accra area blood transfusion center Accra. Ghana J Ghana Sci Assoc. 2011;13(2):64–73. Tettey Y, Adjei A, Ayivase J, Adu-Gyamfi C, Mingle J, Nartey E, et al. Serological evidence of hepatitis E virus infection among volunteer blood donors at the Accra area blood transfusion center Accra. Ghana J Ghana Sci Assoc. 2011;13(2):64–73.
12.
go back to reference Meldal BH, Sarkodie F, Owusu-Ofori S, Allain JP. Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation. Vox Sang. 2013;104(1):30–6.CrossRef Meldal BH, Sarkodie F, Owusu-Ofori S, Allain JP. Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation. Vox Sang. 2013;104(1):30–6.CrossRef
13.
go back to reference Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6(1):108.CrossRef Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6(1):108.CrossRef
14.
go back to reference Obiri-Yeboah D, Asante Awuku Y, Adu J, Pappoe F, Obboh E, Nsiah P, et al. Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. PLoS ONE. 2018;13(1):e0191685.CrossRef Obiri-Yeboah D, Asante Awuku Y, Adu J, Pappoe F, Obboh E, Nsiah P, et al. Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. PLoS ONE. 2018;13(1):e0191685.CrossRef
15.
go back to reference UNICEF. 2018/19 District League Table II with New Perspectives and Modified Methodology: UNICEF; 2019. UNICEF. 2018/19 District League Table II with New Perspectives and Modified Methodology: UNICEF; 2019.
16.
go back to reference Majekodunmi AO, Addo HO, Bagulo H, Bimi L. Integrated value-chain and risk assessment of Pig-Related Zoonoses in Ghana. PLoS ONE. 2019;14(11):e0224918.CrossRef Majekodunmi AO, Addo HO, Bagulo H, Bimi L. Integrated value-chain and risk assessment of Pig-Related Zoonoses in Ghana. PLoS ONE. 2019;14(11):e0224918.CrossRef
17.
go back to reference Lange H, Øverbø J, Borgen K, Dudman S, Hoddevik G, Urdahl AM, et al. Hepatitis E in Norway: seroprevalence in humans and swine. Epidemiol Infect. 2017;145(1):181–6.CrossRef Lange H, Øverbø J, Borgen K, Dudman S, Hoddevik G, Urdahl AM, et al. Hepatitis E in Norway: seroprevalence in humans and swine. Epidemiol Infect. 2017;145(1):181–6.CrossRef
18.
go back to reference Mansuy J-M, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17(12):2309.CrossRef Mansuy J-M, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17(12):2309.CrossRef
19.
go back to reference Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82(5):799–805.CrossRef Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82(5):799–805.CrossRef
20.
go back to reference Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron J-M, Alric L, et al. Performance of HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol. 2013;58(4):624–8.CrossRef Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron J-M, Alric L, et al. Performance of HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol. 2013;58(4):624–8.CrossRef
21.
go back to reference Junaid SA, Agina SE, Abubakar KA. Epidemiology and associated risk factors of hepatitis e virus infection in plateau state, Nigeria. Virology (Auckl). 2014;5:15–26. Junaid SA, Agina SE, Abubakar KA. Epidemiology and associated risk factors of hepatitis e virus infection in plateau state, Nigeria. Virology (Auckl). 2014;5:15–26.
22.
go back to reference Lin C-C, Wu J-C, Chang T-T, Chang W-Y, Yu M-L, Tam AW, et al. Diagnostic value of immunoglobulin G (IgG) and IgM hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol. 2000;38(11):3915–8.CrossRef Lin C-C, Wu J-C, Chang T-T, Chang W-Y, Yu M-L, Tam AW, et al. Diagnostic value of immunoglobulin G (IgG) and IgM hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol. 2000;38(11):3915–8.CrossRef
23.
go back to reference Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol. 2004;11(2):392–8.PubMedPubMedCentral Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol. 2004;11(2):392–8.PubMedPubMedCentral
24.
go back to reference Adjei AA, Aviyase JT, Tettey Y, Adu-Gyamfi C, Mingle JA, Ayeh-Kumi PF, et al. Hepatitis E virus infection among pig handlers in Accra. Ghana East Afr Med J. 2009;86(8):359–63.PubMed Adjei AA, Aviyase JT, Tettey Y, Adu-Gyamfi C, Mingle JA, Ayeh-Kumi PF, et al. Hepatitis E virus infection among pig handlers in Accra. Ghana East Afr Med J. 2009;86(8):359–63.PubMed
25.
go back to reference Traore KA, Ouoba JB, Huot N, Rogee S, Dumarest M, Traore AS, et al. Hepatitis E virus exposure is increased in pork butchers from Burkina Faso. Am J Trop Med Hyg. 2015;93(6):1356–9.CrossRef Traore KA, Ouoba JB, Huot N, Rogee S, Dumarest M, Traore AS, et al. Hepatitis E virus exposure is increased in pork butchers from Burkina Faso. Am J Trop Med Hyg. 2015;93(6):1356–9.CrossRef
26.
go back to reference Temmam S, Besnard L, Andriamandimby SF, Foray C, Rasamoelina-Andriamanivo H, Heraud JM, et al. High prevalence of hepatitis E in humans and pigs and evidence of genotype-3 virus in swine Madagascar. Am J Trop Med Hyg. 2013;88(2):329–38.CrossRef Temmam S, Besnard L, Andriamandimby SF, Foray C, Rasamoelina-Andriamanivo H, Heraud JM, et al. High prevalence of hepatitis E in humans and pigs and evidence of genotype-3 virus in swine Madagascar. Am J Trop Med Hyg. 2013;88(2):329–38.CrossRef
27.
go back to reference Vitral CL, da Silva-Nunes M, Pinto MA, de Oliveira JM, Gaspar AMC, Pereira RCC, et al. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia. BMC Infect Dis. 2014;14(1):1–9.CrossRef Vitral CL, da Silva-Nunes M, Pinto MA, de Oliveira JM, Gaspar AMC, Pereira RCC, et al. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia. BMC Infect Dis. 2014;14(1):1–9.CrossRef
28.
go back to reference Mast EE, Polish LB, Favorov MO, Khudyakova NS, Collins C, Tukei PM, et al. Hepatitis E among refugees in Kenya: minimal apparent person-to-person transmission, evidence for age-dependent disease expression, and new serologic assays. Viral hepatitis and liver disease: Springer; 1994. p. 375–8. Mast EE, Polish LB, Favorov MO, Khudyakova NS, Collins C, Tukei PM, et al. Hepatitis E among refugees in Kenya: minimal apparent person-to-person transmission, evidence for age-dependent disease expression, and new serologic assays. Viral hepatitis and liver disease: Springer; 1994. p. 375–8.
29.
go back to reference Goumba AI, Konamna X, Komas NP. Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui Central African Republic. BMC Infect Dis. 2011;11:93.CrossRef Goumba AI, Konamna X, Komas NP. Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui Central African Republic. BMC Infect Dis. 2011;11:93.CrossRef
30.
go back to reference Corwin A, Putri M, Winarno J, Lubis I, Suparmanto S, Sumardiati A, et al. Epidemic and sporadic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia. Am J Trop Med Hyg. 1997;57(1):62–5.CrossRef Corwin A, Putri M, Winarno J, Lubis I, Suparmanto S, Sumardiati A, et al. Epidemic and sporadic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia. Am J Trop Med Hyg. 1997;57(1):62–5.CrossRef
31.
go back to reference Buti M, Domínguez À, Plans P, Jardí R, Schaper M, Espuñes J, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia Spain. Clin Vaccine Immunol. 2006;13(12):1328–32.CrossRef Buti M, Domínguez À, Plans P, Jardí R, Schaper M, Espuñes J, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia Spain. Clin Vaccine Immunol. 2006;13(12):1328–32.CrossRef
32.
go back to reference Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis. 2009;200(1):48–56.CrossRef Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis. 2009;200(1):48–56.CrossRef
33.
go back to reference Faber MS, Wenzel JJ, Jilg W, Thamm M, Höhle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis. 2012;18(10):1654.CrossRef Faber MS, Wenzel JJ, Jilg W, Thamm M, Höhle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis. 2012;18(10):1654.CrossRef
34.
go back to reference Khuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet. 1993;341(8856):1355.PubMed Khuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet. 1993;341(8856):1355.PubMed
35.
go back to reference Tucker TJ, Kirsch RE, Louw SJ, Isaacs S, Kannemeyer J, Robson SC. Hepatitis E in South Africa: evidence for sporadic spread and increased seroprevalence in rural areas. J Med Virol. 1996;50(2):117–9.CrossRef Tucker TJ, Kirsch RE, Louw SJ, Isaacs S, Kannemeyer J, Robson SC. Hepatitis E in South Africa: evidence for sporadic spread and increased seroprevalence in rural areas. J Med Virol. 1996;50(2):117–9.CrossRef
36.
go back to reference Abdel Rahman MM, Massoud AM, Kamel MA, Sabry AH, Ahmed GN. Risk of hepatitis “E” virus infection among some schistosomiasis patients in Egypt. J Egypt Soc Parasitol. 1995;25(1):115–23.PubMed Abdel Rahman MM, Massoud AM, Kamel MA, Sabry AH, Ahmed GN. Risk of hepatitis “E” virus infection among some schistosomiasis patients in Egypt. J Egypt Soc Parasitol. 1995;25(1):115–23.PubMed
37.
go back to reference Caron M, Kazanji M. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J. 2008;5:158.CrossRef Caron M, Kazanji M. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J. 2008;5:158.CrossRef
38.
go back to reference Vivek R, Chandy GM, Brown DW, Kang G. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India. Trans R Soc Trop Med Hyg. 2010;104(4):307–8.CrossRef Vivek R, Chandy GM, Brown DW, Kang G. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India. Trans R Soc Trop Med Hyg. 2010;104(4):307–8.CrossRef
39.
go back to reference Pavio N, Doceul V, Bagdassarian E, Johne R. Recent knowledge on hepatitis E virus in Suidae reservoirs and transmission routes to human. Vet Res. 2017;48(1):1–14.CrossRef Pavio N, Doceul V, Bagdassarian E, Johne R. Recent knowledge on hepatitis E virus in Suidae reservoirs and transmission routes to human. Vet Res. 2017;48(1):1–14.CrossRef
40.
go back to reference El-Duah P, Dei D, Binger T, Sylverken A, Wollny R, Tasiame W, et al. Detection and genomic characterization of hepatitis E virus genotype 3 from pigs in Ghana Africa. One Health Outlook. 2020;2(1):1–9.CrossRef El-Duah P, Dei D, Binger T, Sylverken A, Wollny R, Tasiame W, et al. Detection and genomic characterization of hepatitis E virus genotype 3 from pigs in Ghana Africa. One Health Outlook. 2020;2(1):1–9.CrossRef
41.
go back to reference Antia RE, Adekola AA, Jubril AJ, Ohore OG, Emikpe BO. Hepatitis E Virus infection seroprevalence and the associated risk factors in animals raised in Ibadan Nigeria. J Immunoassay Immunochem. 2018;39(5):509–20.CrossRef Antia RE, Adekola AA, Jubril AJ, Ohore OG, Emikpe BO. Hepatitis E Virus infection seroprevalence and the associated risk factors in animals raised in Ibadan Nigeria. J Immunoassay Immunochem. 2018;39(5):509–20.CrossRef
42.
go back to reference De Paula SV, Wiele M, Mbunkah AH, Daniel AM, Kingsley MT, Schmidt-Chanasit J. Hepatitis E virus genotype 3 strains in domestic pigs Cameroon. Emerg Infect Dis. 2013;19(4):666–8. De Paula SV, Wiele M, Mbunkah AH, Daniel AM, Kingsley MT, Schmidt-Chanasit J. Hepatitis E virus genotype 3 strains in domestic pigs Cameroon. Emerg Infect Dis. 2013;19(4):666–8.
43.
go back to reference Kaba M, Colson P, Musongela JP, Tshilolo L, Davoust B. Detection of hepatitis E virus of genotype 3 in a farm pig in Kinshasa (Democratic Republic of the Congo). Infect Genet Evol. 2010;10(1):154–7.CrossRef Kaba M, Colson P, Musongela JP, Tshilolo L, Davoust B. Detection of hepatitis E virus of genotype 3 in a farm pig in Kinshasa (Democratic Republic of the Congo). Infect Genet Evol. 2010;10(1):154–7.CrossRef
Metadata
Title
Hepatitis E seroprevalence and risk factors in humans and pig in Ghana
Authors
Husein Bagulo
Ayodele O. Majekodunmi
Susan C. Welburn
Langbong Bimi
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Hepatitis E
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07127-6

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.